B cell malignancies
Clinical trials for B cell malignancies explained in plain language.
Never miss a new study
Get alerted when new B cell malignancies trials appear
Sign up with your email to follow new studies for B cell malignancies, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer drug zanubrutinib tested for Long-Term safety in 955 patients
Disease control OngoingThis study looks at the long-term safety of the drug zanubrutinib in people with B-cell cancers who were already in a related trial. About 955 participants will continue or start taking zanubrutinib and be monitored for side effects and how well the drug controls their cancer. Th…
Matched conditions: B CELL MALIGNANCIES
Phase 3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Cancer drug parsaclisib gets extended trial for B-Cell patients
Disease control OngoingThis study offers continued access to the drug parsaclisib for people with B-cell cancers who were already benefiting from it in earlier trials. About 112 participants will keep taking the same dose, either alone or with other drugs, to monitor long-term safety and tolerability. …
Matched conditions: B CELL MALIGNANCIES
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill targets Hard-to-Treat blood cancers in early human trial
Disease control OngoingThis early-stage trial tests an experimental oral drug called ABBV-525 in people with B-cell blood cancers like lymphoma and leukemia. The study aims to find a safe dose and check for side effects. About 78 adults will take the drug in different dose groups over up to 64 months.
Matched conditions: B CELL MALIGNANCIES
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC